FebriDx® Test Featured in UK National Institute for Health and Care Excellence

Business

Lumos Diagnostics today announced its rapid point-of-care (POC) diagnostic test FebriDx® was featured in a Medtech Innovation Briefing (MIB), as part of the United Kingdom’s National Institute for Health and Care Excellence (NICE) guidance for the COVID-19 pandemic response. This MIB addresses the impact that the FebriDx test can have on the concurrent COVID-19 pandemic and antimicrobial resistance global health crises. “As hospitals and clinics continue to struggle with capacity and patient care during the COVID-19 pandemic, the ability to facilitate prompt and accurate testing is the key to not only better patient care but also an accelerated recovery. FebriDx offers rapid results, which helps clinicians make accurate triage and treatment decisions,” said Robert Sambursky, MD, president and chief executive officer for Lumos Diagnostics. “As the UK continues to work to control the COVID-19 pandemic, the FebriDx MIB will give clinicians critical diagnostic information to improve patient care and therapeutic outcomes, while also protecting their healthcare facilities and communities across the UK.”

Click here for more information.

« View The Wednesday Sep 9, 2020 SRQ Daily Edition
« Back To SRQ Daily Archive

Read More

Local Organizations Bring Choral Singing as a Better Approach to Improving Speech and Voice Disorders in Parkinson's.

Local Organizations Bring Choral Singing as a Better Approach to Improving Speech and Voice Disorders in Parkinson's.

Jan 6, 2023

Let’s Get Physical

Let’s Get Physical

Jan 5, 2023

Sunshine From Darkness, a Non-Profit, Volunteer-Driven Organization

Sunshine From Darkness, a Non-Profit, Volunteer-Driven Organization

Jan 2, 2023

New Chief Operating Officer at HCA Florida Sarasota Doctors Hospital

New Chief Operating Officer at HCA Florida Sarasota Doctors Hospital

Dec 26, 2022